吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Apr 26 2023

Full Issue

Viewpoints: How The US Botched The Covid Response; One Judge Should Not Hold Abortion Hostage

Editorial writers discuss covid, mifepristone , clinical trials and more.

Looking back at the U.S. response to the pandemic, many setbacks and mistakes are well-known. But a closer examination by a team of seasoned experts has brought to the surface a profoundly unsettling conclusion. (4/24)

Mifepristone has been approved by the Food and Drug Administration since 2000 as part of a two-drug protocol that is used to terminate pregnancies. It is estimated that 54% of abortions in the United States use these drugs. Before the federal district court鈥檚 order that the sale and distribution of mifepristone be stopped, never had any judge overruled the FDA鈥檚 approval of a drug. (Erwin Chemerinsky, 4/25)

In the early days of the Covid-19 pandemic, much of the clinical trials industry came to a screeching halt. With the health system focused on this new disease and many trial participants in lockdown, monthly trial starts fell by 50%, McKinsey reported. But it didn鈥檛 have to be this way. (Ben Green, 4/26)

The CDC uses funding to impose policies on states and AIDS service organizations that are not to the benefit of HIV-positives. These seem designed to鈥痠ncrease鈥痗ase counts so as to increase lifetime customers for the lucrative AIDS drug industry. (Tom Busse, 4/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
  • Monday, July 27
  • Friday, July 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF